-
February 1, 2012
Patient Education: Vying for Attention
Over the years, drugmakers have sought to raise awareness that attention-deficit hyperactivity disorder, a condition typically diagnosed in childhood, affects young and old alike. Their efforts have only been partially successful.
Read More
-
January 25, 2012
Five Big Drugs for 2012
These medications could boost the fortunes of companies like Pfizer, Gilead Sciences and Bristol-Myers Squibb.
Read More
-
January 23, 2012
Should Physicians Use Email to Communicate With Patients?
Email has been so commonplace for so long that some people consider it nearly obsolete. But in the health-care profession, its use for communications between doctors and their patients is still controversial.
Read More
-
January 16, 2012
Each month 16.9M access health info via mobiles
According to a new report from comScore, the number of people in the US who access health information from their mobile devices is on the rise.
Read More
-
December 22, 2011
Three key antipsychotics lose patent protection
State Medicaid programs, patients to save as major atypical meds “go generic”
Read More
-
December 6, 2011
Europeans prefer info from drugmakers direct, not on Twitter
As pharma increasingly explores ways of using social media, a survey carried out in Europe suggests that people looking for information about drugmakers and their products are not so enthusiastic.
Read More
-
December 1, 2011
Leadership Exchange: Multichannel Marketing
Choosing your channels and creating an effective integrated campaign is no easy task. Luckily, a panel of experts is here to help.
Read More
-
November 9, 2011
Pelvic floor recon market to shrink by over 15% on safety concerns
The pelvic floor reconstruction market, comprising devices such as the transvaginal meshes which were at the centre of a safety storm this year, will see sales decrease by over 15% this year, according to the Millennium Research Group. The organisation valued the market at around $115m in 2011.
Read More
-
November 8, 2011
Dabigatran's First A Fib Year Starts Warfarin's Decline
For decades, physicians and patients bemoaned the problems and inconveniences of warfarin to prevent strokes caused by atrial fibrillation. A simpler, easier oral anticoagulant was what people wanted and what drove drug companies to try to find alternatives.
Read More
-
November 7, 2011
BlackBerry lauded for enabling disaster recovery efforts
Research In Motion (RIM) is this year’s recipient of the International Medical Corps’ Global Impact award for aiding disaster-recovery efforts worldwide with its BlackBerry smartphone. The 2011 Annual Awards Celebration takes place in Los Angeles next week.
Read More
-
November 7, 2011
MS pipeline flowing, but niche remains for neuroprotection
For decades, people with multiple sclerosis have injected themselves daily with immunosuppressant drugs for lack of a better option, in hopes of mitigating the disease's neurodegenerative effects. But newly designed oral therapies for the disorder have proliferated over the past few years, foretelling a future with fewer pricks.
Read More
-
November 4, 2011
HealthSpring deal shows commercial appeal of ACOs
Cigna Corp.'s proposed $3.8 billion purchase of HealthSpring Inc. is an endorsement of Washington's plan to promote accountable care organizations as a way to both cut health expenditures and improve quality of care.
Read More
-
November 1, 2011
75 percent of nurses own smartphones or tablets
According to a new study conducted by textbook publisher Springer Publishing, 74.6 percent of nurses in the US use smartphones or tablets. Of those smartphone owners, 43.7 percent own an iPhone or iPod Touch, 29.8 percent an Android phone, and 22 percent an iPad.
Read More
-
October 31, 2011
Many patients taking a pass on electronic access to records
Some physicians, however, say there are ways to pique interest in looking at health information.
Read More
-
October 25, 2011
BioReference's genetic-testing business has new tool for detecting rare diseases
Scientists at GeneDx, a subsidiary of Elmwood Park-based BioReference Labs, develop a new genetic test capable of analyzing a patient’s DNA more comprehensively than existing technology.
Read More